Skip to content
Alnylam Pharmaceuticals

Associate Dir, Health Systems, Medical Outcomes Science Liaison (North Central-Chicago)

Chicago, IL; United StatesUnited States
Junior · Medical Affairs - US TTR
POSTED 16 SEPT
Apply Ask
Role
67 days opentrue age
Past the 59d median close
Posted 16 Sept · n=20
Payats field
$188k–254kposted
▲ +145% vs market median $90k
$55k$254k
Market p25–p75
$55k–$141k
Alnylam Pharmaceuticals p25–p75
$205k–$230kn=3
Chicago · n=141 · 365d to 19 Nov
CompanyAlnylam Pharmaceuticals →
113open roles
Opened · 30d
+12
Closed · 30d
−10
Signal
● Steady+2 net
19d of snapshots · 30d window
Market
33,604open · Junior Other
Opened · 7d
+4,14712% of open
All other
622,900open
All tracked boards · live 22 Nov · n=33,604

Overview

The Health System Medical Outcomes Science Liaison (HS MOSL) is a field-based scientific expert who serves as Alnylam's primary medical liaison within integrated delivery networks (IDNs), academic health systems, and organized healthcare entities. The HS MOSL engages formulary decision makers, C-suite healthcare leaders, clinical pharmacists, and broader clinical leaders who influence formulary and access decisions - providing balanced, evidence-based scientific and health economic information that supports informed formulary, access, and clinical pathway decisions while identifying collaborative research opportunities that advance evidence generation.

Territory includes: ND, SD, MN, MI, IN, IL, KY, MO, IA, KS, NE

Key Responsibilities

  • Engage and build peer-level relationships with formulary decision makers, C-suite healthcare leaders, clinical pharmacists, pharmacy directors, and key clinical leaders who influence formulary decisions within IDNs and health systems.
  • Conduct balanced, evidence-based scientific exchange to address data needs, gather insights, and communicate the clinical and economic value of Alnylam's portfolio.
  • In collaboration with the Health System Director (HSD), develop account-specific strategic plans including a detailed assessment of key influencers and decision makers.
  • Collect and share evidence gaps and insights to inform Alnylam's Value, Evidence, and Strategy (VESt) Team and advance meaningful data generation.
  • Engage health system stakeholders in evidence-based scientific and outcomes-focused dialogue, drawing on relevant clinical and health economic data to support awareness of diagnostic and treatment considerations across the disease area at the system level.
  • Identify scientific research collaboration opportunities including real-world evidence generation by leveraging internal stakeholders (Medical Affairs, Value & Access, VESt).
  • Provide HEOR and outcomes data to support formulary review processes, clinical pathway development, and health system value assessments.
  • Support regional and national IDN/healthcare systems congresses as needed.
  • Collaborate closely with MSL colleagues to ensure integrated territory-level scientific strategy across clinical and system-level stakeholders.
  • Maintain a thorough understanding of compliance requirements and applicable PhRMA Codes, OIG guidelines, FDA laws, and Alnylam's policies.
  • Apply business acumen to prioritize health system engagements that maximize scientific impact and access for patients.
  • Independently and proactively applies strategic thinking, scientific expertise, engagement excellence, integrity-driven conduct, and cross-functional collaboration within the health system driving strong execution and continuous improvement across access stakeholder engagement.

Qualifications

  • Required: Advanced degree - MD, DO, PharmD, or PhD in a relevant life science discipline. HEOR fellowship, MS, MBA, or MPH is a plus.
  • 5+ years of Medical Affairs experience in pharmaceutical or biotech; prior field-based experience working directly with health systems or IDNs strongly preferred. Experience with federal health systems (VA, DoD) is a plus.
  • Demonstrated understanding of pharmacoeconomic and health outcomes research principles.
  • Solid working knowledge of US healthcare ecosystems, IDN structure, and formulary decision-making processes.
  • Strong therapeutic area knowledge; rare disease experience preferred.
  • Solid working knowledge of regulatory and compliance environment including PhRMA, OIG, and FDA guidelines.
  • Excellent written and verbal communication skills; ability to engage diverse audiences from clinical staff to C-suite system leaders.
  • Ability to travel up to 75%; must reside within assigned territory. Valid driver's license required.

About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

Source · Alnylam PharmaceuticalsFirst seen 4 Nov1 editsOriginal ↗